| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/04/2002 | US6399764 DNA molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
| 06/04/2002 | US6399763 Method for producing antibody fragments |
| 06/04/2002 | US6399762 Methods and compositions for diagnosing and treating chromosome -18p related disorders |
| 06/04/2002 | US6399755 A nucleic acid; diagnosis and therapy for human cancers |
| 06/04/2002 | US6399750 IGG separation medium |
| 06/04/2002 | US6399747 A polypeptide for screening transgenic animals and testing drugs for their ability to block cell proliferation |
| 06/04/2002 | US6399745 Use of leptin antagonists for treating insulin resistance in type II diabetes |
| 06/04/2002 | US6399573 Interleukin-1 receptor antagonist beta (IL-1rabeta) |
| 06/04/2002 | US6399571 Polypeptides |
| 06/04/2002 | US6399569 Gastrointestinal disorders; antiulcer agents |
| 06/04/2002 | US6399386 Transforming yeast cells with a cdna expression library of interest; detecting protein kinase activity in clonally derived cells; the tyrosine kinase receptor is activated by binding of a ligand to the extracellular domain |
| 06/04/2002 | US6399373 Nucleic acid encoding a retinoblastoma binding protein (RBP-7) and polymorphic markers associated with said nucleic acid |
| 06/04/2002 | US6399368 A genetically engineered cloning vector containing a inducible promoter, leader sequence and a soluble t-cell receptor variable domain; therapy for autoimmune diseases and cancer |
| 06/04/2002 | US6399350 Screening for modulators by exposing kuz polypeptide to protease substrate in presence of modulating agent which can be an antibody, dominant negative fragment of the polypeptide or enzyme inhibitor |
| 06/04/2002 | US6399330 Nucleotide and amino acid sequences of crystal/insecticidal proteins; active against japanese beetle and red flour beetle; biological pest control |
| 06/04/2002 | US6399328 Amino acid sequence; hybridization probes; amplification primers; anticarcinogenic agents; antitumor agents |
| 06/04/2002 | US6399327 Dna sequence which codes for specific amino acid sequence of a polypeptide capable of binding to mort-1 which in turn binds to intracellular domain of fas receptor |
| 06/04/2002 | US6399318 Immunoassay for phthalic acid esters |
| 06/04/2002 | US6399315 Drug screening by contacting cells transfected with nucleic acid encoding a g-protein coupled receptor which binds corticotropin-releasing factor, then monitoring cell for compounds which bind the receptor |
| 06/04/2002 | US6399312 Myostatin gene promoter and inhibition of activation thereof |
| 06/04/2002 | US6399294 Probes; primers; immunogens; for diagnosis of human immunodeficiency virus infections |
| 06/04/2002 | US6399071 Removal of xenobodies from body fluid |
| 06/04/2002 | US6399068 Cancer treatment, interleukins, fusion proteins, cell markers |
| 06/04/2002 | US6399067 Methods and compositions for impairing multiplication of HIV-1 |
| 06/04/2002 | US6399066 Capsular polysaccharide adhesin antigen, preparation, purification and use |
| 06/04/2002 | US6399065 Methods for modulating SLAM-expressing T cells |
| 06/04/2002 | US6399063 Monoclonal antibodies directed to the HER2 receptor |
| 06/04/2002 | US6399062 Murine monoclonal antibody protective against Plasmodium vivax malaria |
| 06/04/2002 | US6399061 Monoclonal secreted by atcc deposit no. hb11388 and transfectoma tcae8 accorded atcc deposit no. 69119; parenteral injection |
| 06/04/2002 | CA2331934A1 Protein and its encoding nucleotide sequences for diagnosis, prevention and treatment of lung injuries and disorders |
| 06/04/2002 | CA2014459C Targeted forms of methyltrithio antitumor agents |
| 06/04/2002 | CA2011450C Recombinant b-chain of the il-2 receptor |
| 06/04/2002 | CA1341364C Single polypeptide chain binding molecules |
| 06/01/2002 | CA2325088A1 Novel membrane fusion proteins derived from poikilothermic reovirus |
| 05/30/2002 | WO2002042777A2 Modulation of the interaction between evh1 domains |
| 05/30/2002 | WO2002042776A2 Compositions and methods relating to prostate specific genes and proteins |
| 05/30/2002 | WO2002042774A1 Highly efficient method of screening antibody |
| 05/30/2002 | WO2002042462A2 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 05/30/2002 | WO2002042456A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 05/30/2002 | WO2002042455A2 Modifier of organelle metalbolism |
| 05/30/2002 | WO2002042444A2 Fungal gene cluster associated with pathogenesis |
| 05/30/2002 | WO2002042441A2 VON WILLEBRAND FACTOR (vWF) CLEAVING PROTEASE POLYPEPTIDE, NUCLEIC ACID ENCODING THE POLYPEPTIDE AND USE OF POLYPEPTIDE |
| 05/30/2002 | WO2002042437A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 05/30/2002 | WO2002042436A2 Isolated human phosphatase proteins, nucleic acid molecules encoding them, and uses thereof |
| 05/30/2002 | WO2002042432A2 Epothilone resistant cell lines |
| 05/30/2002 | WO2002042417A2 Human erg2 potassium channel |
| 05/30/2002 | WO2002042333A1 Anti-cd14 monoclonal antibody having effect of inhibiting cd14/tlr binding |
| 05/30/2002 | WO2002042332A2 Truncated cd200 |
| 05/30/2002 | WO2002042330A2 Cystoskeleton-associated proteins |
| 05/30/2002 | WO2002041912A1 Drugs and foods improving the quality of life and process for producing the same |
| 05/30/2002 | WO2002041842A2 Antibody pti-hs7 for treatment of alzheimer's disease and other amyloidoses and parkinson's disease |
| 05/30/2002 | WO2002028440B1 Methods and compositions for modulating t cell activation and uses thereof |
| 05/30/2002 | WO2002022782A3 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 05/30/2002 | WO2002020736A9 Proteases |
| 05/30/2002 | WO2002018581A9 G-protein coupled receptors |
| 05/30/2002 | WO2002012437A3 Production of humanized antibodies in transgenic animals |
| 05/30/2002 | WO2002009643A3 Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| 05/30/2002 | WO2002002738A3 Host cells containing multiple integrating vectors |
| 05/30/2002 | WO2001098534A3 Matrix screening method |
| 05/30/2002 | WO2001095928A3 Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking lfa-1 mediated adhesion |
| 05/30/2002 | WO2001094380A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 05/30/2002 | WO2001087934A3 Treatment of neoplasia/transformation using a pituitary tumor transforming gene carboxy terminal peptides |
| 05/30/2002 | WO2001083561A3 Anthrax-specific antigen, vaccines comprising said antigen, anthrax-specific antibodies, and their uses |
| 05/30/2002 | WO2001081413A3 Isolated human transporter proteins, nucleic acids and uses thereof |
| 05/30/2002 | WO2001073094A3 Novel sperm-dna complexes for genetically modifying non-human animals |
| 05/30/2002 | WO2001068704A3 G-protein coupled receptors |
| 05/30/2002 | WO2001066746A3 G-protein coupled receptor related polypeptides |
| 05/30/2002 | WO2001064877A3 Human schizophrenia gene |
| 05/30/2002 | WO2001040306A9 Human antibodies as detection reagents |
| 05/30/2002 | WO2001029063A8 Death domain-containing receptor polynucleotides, polypeptides, and antibodies |
| 05/30/2002 | WO2000078952A8 Human rna metabolism proteins (rmep) |
| 05/30/2002 | US20020065398 Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (egf-r); diagnostic and therapeutic use |
| 05/30/2002 | US20020065395 Polypeptide for use as diagnostic tool in screening bactericides |
| 05/30/2002 | US20020065393 Human hypoxanthine- (guanine) phosphoribosy1 transferase-2 |
| 05/30/2002 | US20020065238 EPO primary response gene, EPRG3pt |
| 05/30/2002 | US20020065237 SBHWSB1 polypeptides/polynucleotides produced by recombinant techniques; gene therapy; diagnostic tests; agonists; antagonists; "positional cloning"; sequence of Serine(S), Aspargine/Asparic Acid(W), Histidine (H) and Tryptophan (T) |
| 05/30/2002 | US20020065225 Methods of determining altered NDPK functions and the diagnosis of cystic fibrosis |
| 05/30/2002 | US20020065220 For use in diagnosis and therapy of disorders treating disorders related to these novel human immunoglobulin-like (Ig- like) proteins |
| 05/30/2002 | US20020065216 Novel method of diagnosing and treating gliomas |
| 05/30/2002 | US20020065210 DcR3 polypeptide, a TNFR homolog |
| 05/30/2002 | US20020064865 Crystal protein for use in bological pest control |
| 05/30/2002 | US20020064862 Preventing viral replication in cells; obtain cells, incubate with viricide, monitor cells for reduced viral activity |
| 05/30/2002 | US20020064858 Compositions including glycosaminoglycans degrading enzymes and use of same against surface protected bacteria |
| 05/30/2002 | US20020064856 Novel proteases |
| 05/30/2002 | US20020064851 Peptide for use in development of human diagnostics and therapeutics; for use in deection and treatment of cancer, inflammation, immune disorders and development defects |
| 05/30/2002 | US20020064848 Novel histidinol dehydrogenase |
| 05/30/2002 | US20020064846 Protein for use treatment of diabetes |
| 05/30/2002 | US20020064844 Nucleotide sequences coding enzymatic polypeptide for use in the diagnostic tool in detection, prevention and treatment of nervous system, reproductive and vascular systems disorders |
| 05/30/2002 | US20020064843 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/30/2002 | US20020064829 Human tumor necrosis factor delta and epsilon |
| 05/30/2002 | US20020064826 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 05/30/2002 | US20020064823 Nucleotide sequences which code binding protein for use in human therapeutics and gene therapy |
| 05/30/2002 | US20020064821 Isolated human ion channel proteins, nucleic acid molecules encoding human ion channel proteins, and uses thereof |
| 05/30/2002 | US20020064818 Nucleotide sequences coding preferential polypeptide; for use in diagnosis and treatment of cancer, nervous system, inflammatory and immunological disorders |
| 05/30/2002 | US20020064805 Isolated nucleic acids, vectors and host cells encoding ErbB3 antibodies |
| 05/30/2002 | US20020064803 Novel antibody compositions for preparing enriched eosinophil preparations |
| 05/30/2002 | US20020064796 Generating preferential amino acid sequences on substrate; obtain substrate, deblock, expose to amino acids, recover preferential particles |
| 05/30/2002 | US20020064786 Cancer diagnosis and therapy based on mutations in TGF-beta receptors |
| 05/30/2002 | US20020064785 Gene detection assay for improving the likelihood of an effective response to an ErbB antagonist cancer therapy |
| 05/30/2002 | US20020064535 Such as human granulocytic ehrlichiosis; polypeptides of antigenic portion(s) of an Ehrlichia antigen and DNA sequences encoding them; vaccines; detection kits |